First Quadrant L P

SEC CIK: 0001014736
Latest filing: Apr 21, 2022

SEC filings (opens in a new tab)

CTMX holding history

CytomX Therapeutics, Inc. in every 13F filed by First Quadrant L P, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTMX overview All 13F holders of CTMX Full Q1 2022 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of CTMX by First Quadrant L P, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−3,100−100.0%	Sold out	Holders
Q3 2021	3,100	$16.0K	<0.1%	−40,100−92.8%	Reduced	Holders
Q2 2021	43,200	$273.0K	<0.1%	−43,600−50.2%	Reduced	Holders
Q1 2021	86,800	$671.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.